Skip to main content

Centene Corp

Exchange: NYSESector: HealthcareIndustry: Healthcare Plans

Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach with local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.

Did you know?

Earnings per share grew at a 20.1% CAGR.

Current Price

$53.34

-0.65%

GoodMoat Value

$1901.11

3464.1% undervalued
Profile
Valuation (TTM)
Market Cap$26.23B
P/E-4.07
EV$13.21B
P/B1.31
Shares Out491.77M
P/Sales0.13
Revenue$198.10B
EV/EBITDA

Centene Corp (CNC) Dividends

GoodMoat Analysis

Based on data as of March 26, 2026

Centene Corp does not pay a dividend. While its free cash flow yield is exceptionally high at 26.9%, the company's current negative profitability and elevated debt levels suggest capital is being prioritized for debt management and operational stability rather than shareholder payouts.

Read full analysis
Centene Corp (CNC) is a non-dividend payer. For an income-focused investor, this immediately makes it an unfavourable candidate. The primary reason is the company's current lack of GAAP profitability, a key Quality Indicator. With a negative profit margin of -3.4% and negative EPS of -$13.53, the traditional payout ratio is not applicable as there are no earnings to pay out from. However, analyzing the company's cash generation and balance sheet provides insight into its capacity to potentially initiate a dividend in the future. The free cash flow (FCF) yield is remarkably strong at 26.9%, which far exceeds the framework's favourable threshold of a >10-15% FCF margin. This indicates the business is generating substantial cash from operations. The balance sheet shows a Debt/Equity ratio of 0.87. While not alarmingly high, it is above the framework's ideal low/zero debt target (Debt/EBITDA < 1.0x). Combined with the negative ROE of -33.4%, this suggests capital is likely being allocated to service debt and fund operations rather than returned to shareholders. The company's 23.2% YoY revenue growth indicates it is in a phase where reinvesting capital into the business or strengthening the balance sheet is management's priority. Compared to the sector, where many established healthcare plans offer modest yields, Centene's capital allocation strategy currently focuses on financial stability and growth over direct income distribution. Analysis based on data as of 2024-07-21.

Dividend Overview

Dividend Yield

Dividend / Share

Key Metrics

Market Cap

$26.23B

P/E Ratio

-4.07

Forward P/E

EPS

$-13.53

PEG Ratio

-0.22

Book Value

$40.57

Dividend Yield

Profit Margin

-3.25%

ROE

-32.30%

Dividend History

Dividend Safety

CNC Dividend Analysis

Centene Corp (CNC) dividend analysis including yield, payout history, and sustainability metrics.

P/E ratio: -4.07. Profit margin: -3.25%. Free cash flow: $4.32B. This page shows Centene Corp's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.

GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Centene Corp's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.